Utilization of Glucose-lowering Drugs in Patients With T2dm and Established Cvd in Us: a Descriptive Study Using Optum Clinformatics Data
Year: 2020
Type: article
Study design: Observational Study
Abstract: People with type 2 diabetes mellitus (T2DM) have increased risks of cardiovascular morbidity and mortality. Glucagon-like peptide-1 receptor agonists (GLP-1 RA) and sodium-glucose cotransporter-2 inhibitors (SGLT-2i) have been shown to reduce the risks of CV events, but their use in clinical
Authors: Michael Ganz, Anastasia Ustyugova, Nicola Sawalhi-Leckenby, Sabrina de Souza, Lu Zhang, Erik Gunnarsson, Ran Gao, Nihar R. Desai
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,000
OpenAlex ID: W3010652818